Navigation Links
WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
Date:2/19/2008

NEW YORK and SAN FRANCISCO, Feb. 19 /PRNewswire/ -- WeissComm Partners, the largest independent communications agency focused on the healthcare industry, today announced the appointment of Tom Jones as managing director. Jones joins WeissComm from Novartis Pharmaceuticals Corporation where he was executive director of communications, overseeing the creation, development and implementation of public relations programs for the company's growth driver brands. Prior to that, he was vice president and group manager at Ketchum where he contributed greatly to the growth of the healthcare practice.

For more than 15 years, Jones has developed and executed award-winning public relations and corporate communications initiatives, built and managed high-performance teams, and provided measurable business results for leading pharmaceutical and biotechnology companies, including AstraZeneca, Aventis, Genentech, Merck, Novartis and Pfizer.

"PR has never been more important to the healthcare industry," said Diane Weiser, COO of WeissComm Partners. "Tom is a trusted colleague with a proven track record who can hit the ground running to provide clients with the no-nonsense, on-target, strategic counsel and execution they have come to expect from our team."

Jones has directed consumer and professional communications programs on behalf of some of the world's largest prescription medicines across a broad range of therapeutic areas, including neurology, cardiology, diabetes, respiratory, dermatology, arthritis and gastrointestinal disorders. As part of these initiatives, he has developed and managed corporate and brand communications, consumer and professional outreach, issues management, media and advocacy relations, corporate reputation management, leadership communications, internal communications and new media initiatives.

"I joined WeissComm to be part of a truly senior-based team of healthcare professionals and apply my agency and corporate in-house experience to a diverse group of healthcare clients," said Jones. "I am looking forward to working with respected and trusted peers and colleagues to expand WeissComm's global product communications offering and continue to raise the bar on its client-agency partnerships."

About WeissComm Partners

WeissComm Partners is a full-service public relations agency focused exclusively on serving the corporate and product communications needs of leading biotechnology, pharmaceutical, device and diagnostic companies. At WeissComm, senior counselors are the client's everyday team. WeissComm's team of seasoned professionals specialize in healthcare marketing, corporate and product PR, investor and advocacy relations, clinical trial recruitment and grassroots direct-to-patient PR programs. Ranked among the top independent PR firms in the United States, WeissComm serves clients globally with offices in San Francisco, New York and Chicago, and in London via a strategic alliance with Resolute Communications. For more information, please visit http://www.wcpglobal.com.


'/>"/>
SOURCE WeissComm Partners
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. MDS to Present at Thomas Weisel Partners Healthcare Conference
8. Lutheran Senior Services Partners with Silverchair Learning Systems to Enhance Employee Training and Education
9. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... and Shelton, CT (PRWEB) , ... May 02, 2016 , ... ... President and Owner of New England Low Vision and Blindness (NELV&B) , announces ... add more flexibility and convenience for people with vision impairments to get assessments, hands-on ...
(Date:5/1/2016)... ... May 01, 2016 , ... ... that gives new mothers a better understanding of what to expect after they ... Adjusting to baby postpartum, · The blues and depression, · Breastfeeding beyond postpartum ...
(Date:4/30/2016)... ... April 30, 2016 , ... Create ... Abstract users can distort and manipulate three-dimensional shapes with ease all within ... ranks, point, lines, polygons, polygon texture animation, opacity texture animation, overall shape texture ...
(Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published ... her enthusiasm for Botox and lip injections, which she underwent in order to feel ... Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 New ... 2016" is a report that provides an overview ... R&D pipelines by identifying new targets and MOAs ... Company Profiles discussed in this H1 2016 Osteoarthritis ... Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, ...
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
(Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
Breaking Medicine Technology: